Insider Transactions in Q4 2024 at Hca Healthcare, Inc. (HCA)
Insider Transaction List (Q4 2024)
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Nov 14
2024
|
Kathleen M Whalen SVP & Chief Ethics Officer |
SELL
Open market or private sale
|
Direct |
1,474
-13.49%
|
$526,218
$357.99 P/Share
|
|
Nov 14
2024
|
Jon M Foster EVP and COO |
SELL
Payment of exercise price or tax liability
|
Direct |
20,902
-44.3%
|
$7,211,190
$345.51 P/Share
|
|
Nov 14
2024
|
Jon M Foster EVP and COO |
BUY
Exercise of conversion of derivative security
|
Direct |
36,600
+43.69%
|
$3,696,600
$101.16 P/Share
|
|
Nov 14
2024
|
Jon M Foster EVP and COO |
BUY
Bona fide gift
|
Indirect |
19,955
+26.43%
|
-
|
|
Nov 14
2024
|
Jon M Foster EVP and COO |
SELL
Bona fide gift
|
Direct |
19,955
-34.69%
|
-
|
|
Nov 14
2024
|
Jon M Foster EVP and COO |
BUY
Other acquisition or disposition
|
Indirect |
9,502
+12.83%
|
$3,344,704
$352.74 P/Share
|
|
Nov 14
2024
|
Jon M Foster EVP and COO |
SELL
Other acquisition or disposition
|
Direct |
9,502
-23.73%
|
$3,344,704
$352.74 P/Share
|
|
Nov 14
2024
|
Erol R Akdamar Group President |
SELL
Open market or private sale
|
Direct |
2,900
-29.77%
|
$1,023,700
$353.0 P/Share
|
|
Nov 14
2024
|
Phillip G Billington SVP-Internal Audit Services |
SELL
Open market or private sale
|
Direct |
3,897
-6.89%
|
$1,363,950
$350.0 P/Share
|
|
Nov 12
2024
|
Erol R Akdamar Group President |
SELL
Payment of exercise price or tax liability
|
Direct |
10,257
-51.29%
|
$3,589,950
$350.53 P/Share
|
|
Nov 12
2024
|
Erol R Akdamar Group President |
BUY
Exercise of conversion of derivative security
|
Direct |
20,000
+50.0%
|
$1,360,000
$68.96 P/Share
|
|
Nov 12
2024
|
Phillip G Billington SVP-Internal Audit Services |
SELL
Payment of exercise price or tax liability
|
Direct |
4,103
-6.76%
|
$1,436,050
$350.53 P/Share
|
|
Nov 12
2024
|
Phillip G Billington SVP-Internal Audit Services |
BUY
Exercise of conversion of derivative security
|
Direct |
8,000
+11.64%
|
$544,000
$68.96 P/Share
|
|
Nov 11
2024
|
Kathleen M Whalen SVP & Chief Ethics Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
3,236
-22.85%
|
$1,155,252
$357.99 P/Share
|
|
Nov 11
2024
|
Kathleen M Whalen SVP & Chief Ethics Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
4,710
+24.96%
|
$814,830
$173.12 P/Share
|
|
Oct 30
2024
|
Patricia F Elcan > 10% Shareholder |
BUY
Other acquisition or disposition
|
Indirect |
1,021,199
+14.38%
|
$368,652,839
$361.55 P/Share
|
|
Oct 30
2024
|
Patricia F Elcan > 10% Shareholder |
SELL
Other acquisition or disposition
|
Indirect |
1,021,199
-51.82%
|
$368,652,839
$361.55 P/Share
|